International Isotopes Revenue 2010-2024 | INIS

International Isotopes revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
International Isotopes Annual Revenue
(Millions of US $)
2024 $14
2023 $12
2022 $11
2021 $10
2020 $9
2019 $9
2018 $10
2017 $7
2016 $7
2015 $7
2014 $8
2013 $7
2012 $8
2011 $9
2010 $6
2009 $6
International Isotopes Quarterly Revenue
(Millions of US $)
2024-12-31 $4
2024-09-30 $4
2024-06-30 $3
2024-03-31 $3
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $2
2022-03-31 $3
2021-12-31 $2
2021-09-30 $3
2021-06-30 $3
2021-03-31 $2
2020-12-31 $2
2020-09-30 $3
2020-06-30 $2
2020-03-31 $2
2019-12-31 $2
2019-09-30 $2
2019-06-30 $2
2019-03-31 $3
2018-12-31 $2
2018-09-30 $3
2018-06-30 $2
2018-03-31 $3
2017-12-31 $2
2017-09-30 $2
2017-06-30 $2
2017-03-31 $2
2016-12-31 $2
2016-09-30 $1
2016-06-30 $2
2016-03-31 $2
2015-12-31 $2
2015-09-30 $2
2015-06-30 $2
2015-03-31 $2
2014-12-31 $2
2014-09-30 $2
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $2
2013-03-31 $2
2012-12-31 $2
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $2
2011-09-30 $2
2011-06-30 $3
2011-03-31 $2
2010-12-31 $2
2010-09-30 $2
2010-06-30 $1
2010-03-31 $1
2009-12-31 $2
2009-09-30 $1
2009-06-30 $1
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.026B $0.014B
International Isotopes Inc., manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.497B 15.05
Kewaunee Scientific (KEQU) United States $0.095B 6.71
Harvard Bioscience (HBIO) United States $0.017B 0.00